Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 3601-3650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07012044
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
PHASE1Not yet recruiting
47 participants
Started: Oct 31, 2025 · Completed: Jan 1, 2026
3 conditions1 sponsor0 locations
NCT07108452
Using an AI Mobile Application to Promote Healthy Eating
NANot yet recruiting
114 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT07032506
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
NANot yet recruiting
320 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2031
1 condition1 sponsor3 locations
NCT07075237
Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia
PHASE4Not yet recruiting
120 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06904287
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
PHASE3Not yet recruiting
100 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06945809
Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
NANot yet recruiting
204 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2032
2 conditions1 sponsor0 locations
NCT07036705
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2
NARecruiting
40 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT06917313
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
PHASE2Not yet recruiting
92 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT07011615
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
NANot yet recruiting
120 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2026
1 condition2 sponsors0 locations
NCT06623240
HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
PHASE2Recruiting
66 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06948214
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
PHASE3Recruiting
150 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT07148232
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
PHASE4Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
5 conditions2 sponsors1 location
NCT07188506
Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth People
NANot yet recruiting
180 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
4 conditions1 sponsor1 location
NCT07189104
SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Early Childhood Education and Care
NANot yet recruiting
120 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT07193264
Impact of Chronic and Acute Caffeine Intake on the Hematopoietic System
NANot yet recruiting
100 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2028
1 condition4 sponsors1 location
NCT07197762
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
PHASE4Not yet recruiting
125 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT07196332
Recovering Sleep After Trauma
NANot yet recruiting
20 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT07196774
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
PHASE3Not yet recruiting
650 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT07195812
Rivaroxaban for Slow Coronary Flow After PCI in STEMI
PHASE4Not yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: May 31, 2028
2 conditions4 sponsors0 locations
NCT07197775
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
N/ANot yet recruiting
500 participants
Started: Oct 31, 2025 · Completed: May 31, 2032
5 conditions1 sponsor0 locations
NCT07195864
"Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the Medicines in Special Situations (Medicamentos en Situaciones Especiales) Program in Spain."
N/ANot yet recruiting
24 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT07197788
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
NANot yet recruiting
50 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
5 conditions1 sponsor0 locations
NCT07181876
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
N/ANot yet recruiting
140 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2029
1 condition2 sponsors2 locations
NCT07181200
Urine Pneumococcal Antigen Project
N/ANot yet recruiting
350 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors0 locations
NCT06532773
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
NANot yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT06638619
Comparative Efficacy of Saccadic and Biofeedback Training in Homonymous Hemianopia
NANot yet recruiting
20 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT05706116
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
PHASE1Recruiting
18 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
3 conditions2 sponsors2 locations
NCT06341452
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
NANot yet recruiting
130 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06654193
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
PHASE1/PHASE2Not yet recruiting
70 participants
Started: Oct 31, 2025 · Completed: Jan 1, 2028
1 condition4 sponsors3 locations
NCT07181863
Technology-Enabled Collaborative Care for Diabetes and Mental Health
NANot yet recruiting
160 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: May 3, 2027
4 conditions1 sponsor1 location
NCT07127016
Mindfulness in Nonflaccid Facial Paralysis
NANot yet recruiting
24 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06610942
Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis
N/ANot yet recruiting
100 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT07189572
Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma
PHASE3Not yet recruiting
168 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
5 conditions3 sponsors0 locations
NCT07196371
Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
NANot yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition4 sponsors3 locations
NCT06764927
Fibrinogen in Liver Transplant Subjects
PHASE4Not yet recruiting
30 participants
Started: Oct 31, 2025 · Completed: Mar 1, 2026
1 condition1 sponsor3 locations
NCT06705478
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
PHASE2Not yet recruiting
186 participants
Started: Oct 31, 2025 · Completed: Dec 2, 2026
3 conditions2 sponsors39 locations
NCT07087015
Efficacy of Cervical Sympathetic Blocks for PTSD
NANot yet recruiting
20 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06712641
Aminoglycosides in Early Sepsis
PHASE4Not yet recruiting
1,900 participants
Started: Oct 31, 2025 · Completed: May 31, 2033
1 condition2 sponsors2 locations
NCT07196709
Effect of High-power Laser Acupuncture on Fatigue and Proprioception in Low Back Pain
NANot yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07189390
The Bloom Infant Probiotic (BIP) Study
PHASE2Not yet recruiting
360 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
5 conditions6 sponsors2 locations
NCT07197814
Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy
NANot yet recruiting
29 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT07129187
SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response
PHASE2Not yet recruiting
30 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2030
4 conditions1 sponsor0 locations
NCT07196514
Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
NARecruiting
80 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT07110142
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
NANot yet recruiting
40 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT07108387
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
PHASE2Not yet recruiting
78 participants
Started: Oct 31, 2025 · Completed: Feb 1, 2029
1 condition1 sponsor7 locations
NCT06739447
Hospital Based Continuous Patient Monitoring System
NANot yet recruiting
250 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2031
4 conditions5 sponsors0 locations
NCT07107009
ClimAIr: AI to Assess the Impact of Pollution and Climate on Respiratory Health in Europe
N/ANot yet recruiting
1,906 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
2 conditions2 sponsors0 locations
NCT06894498
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
N/ANot yet recruiting
100 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
2 conditions1 sponsor4 locations
NCT07107529
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
PHASE2Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2034
1 condition6 sponsors0 locations